Astrazeneca (AZN) Long-Term Deferred Tax (2009 - 2026)
Astrazeneca (AZN) reported Long-Term Deferred Tax of $6.49 billion for Q2 2026, up 3.7% from $6.26 billion a year earlier and up 16.0% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends
At the end of FY2025, Astrazeneca posted Long-Term Deferred Tax of $5.82 billion, up 8.8% from FY2024.
- Long-Term Deferred Tax has increased for three consecutive years, with a five-year compound annual growth rate of 11.1% (FY2020 to FY2025).
- By year, Long-Term Deferred Tax came in at $5.35 billion in FY2024 (+13.3%), $4.72 billion in FY2023 (+44.6%), $3.26 billion in FY2022 (-24.6%) and $4.33 billion in FY2021 (+25.9%).
- The Q2 2026 figure ranks as the highest quarterly Long-Term Deferred Tax in data going back to Q1 2009.
- Year over year, Long-Term Deferred Tax gained in seven of the last eight quarters, with growth averaging 16.0%.
- The high point for year-over-year Long-Term Deferred Tax in five years was Q4 2023 (growth of 44.6%); the low point was Q4 2022 (a decline of 24.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.59 billion (Q1 2026), $5.82 billion (Q4 2025) and $6.13 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.49 Bn |
| Mar 31, 2026 | 5.59 Bn |
| Dec 31, 2025 | 5.82 Bn |
| Sep 30, 2025 | 6.13 Bn |
| Jun 30, 2025 | 6.26 Bn |
| Mar 31, 2025 | 6.10 Bn |
| Dec 31, 2024 | 5.35 Bn |
| Sep 30, 2024 | 5.34 Bn |
| Jun 30, 2024 | 4.73 Bn |
| Mar 31, 2024 | 4.62 Bn |
| Dec 31, 2023 | 4.72 Bn |
| Sep 30, 2023 | 4.06 Bn |
| Jun 30, 2023 | 3.74 Bn |
| Mar 31, 2023 | 3.50 Bn |
| Dec 31, 2022 | 3.26 Bn |
| Sep 30, 2022 | 3.44 Bn |
| Jun 30, 2022 | 4.14 Bn |
| Mar 31, 2022 | 4.20 Bn |
| Dec 31, 2021 | 4.33 Bn |
| Sep 30, 2021 | 3.70 Bn |
API Access
Astrazeneca Long-Term Deferred Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-deferred-tax", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();